Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TherapeuticsMD (TXMD): Well Positioned Ahead of A Pivotal Year - Cowen
-
TherapeuticsMD (TXMD) PT Maintained at $16 at Cowen; 'TX-004HR Opportunity Remains on Track, Valuation Inflection Should be Nearing'
-
TherapeuticsMD (TXMD) PT Raised to $16 at Cowen
-
TherapeuticsMD: Meeting Details Indicated There Could be a Straightforward Resolution - Cowen
-
TherapeuticsMD (TXMD) Delay Likely to be Minor at Worst - Cowen
-
TherapeuticsMD Announces Presentation at Cowen and Company 37th Annual Healthcare Conference on March 7
-
Pre-Open Stock Movers 04/04: (VA) (RKUS) (EW) Higher; (SUNE) (BABY) (SWHC) Lower (more...)
-
TherapeuticsMD to Present Data from Phase 3 Rejoice Trial at Upcoming Investor & Medical Conferences
-
Trading Radar for 2/25: Baidu (BIDU), Best Buy (BBY), Sears (SHLD), Weight Watchers (WTW) Report
-
TherapeuticsMD Announces Closing of Common Stock Offering
-
TherapeuticsMD (TXMD) Prices $125M Common Stock Offering at $8.25/Share
-
TherapeuticsMD Announces Pricing of $125 Million Common Stock Offering
-
TherapeuticsMD (TXMD) Announces $125M Common Stock Offering
-
TherapeuticsMD Announces $125 Million Offering of Common Stock
-
TherapeuticsMD (TXMD) Prices 13.6M Common Offering at $4.05/Share
-
TherapeuticsMD (TXMD) Reports Common Stock Offering
-
TherapeuticsMD (TXMD) Prices 9M Share Offering at $7.10
-
TherapeuticsMD (TXMD) Announces 9M Common Secondary Offering
-
TherapeuticsMD (TXMD) Prices 13.75M Offering at $2.40/Share

